![Douglas Snyder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Snyder
General Counsel bei
IDEAYA BIOSCIENCES, INC.
Vermögen: 77 522 $ am 30.06.2026
Profil
Douglas B. Snyder is currently Chief Legal Officer at IDEAYA Biosciences, Inc. Formerly, Mr. Snyder was Vice-President & Associate General Counsel at GSK Plc from 1999 to 2005, Secretary, Vice President & General Counsel at Eisai, Inc. from 2005 to 2012, Associate General Counsel at US Food & Drug Administration from 1994 to 1999, Secretary, Senior Vice President & General Counsel at Actelion US Holding Co. from 2012 to 2017, and Secretary, Executive VP & Chief Legal Officer at GW Pharmaceuticals Ltd. from 2017 to 2022.
Education includes undergraduate studies at Dickinson College and graduate studies at Columbus School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 2.080 ( 0 % ) | 77 522 $ | 30.06.2026 |
Aktive Positionen von Douglas Snyder
| Unternehmen | Position | Beginn |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | General Counsel | 18.09.2024 |
Ehemalige bekannte Positionen von Douglas Snyder
| Unternehmen | Position | Ende |
|---|---|---|
| GW PHARMACEUTICALS PLC | General Counsel | 01.01.2022 |
Actelion US Holding Co.
 Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | General Counsel | 01.01.2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | General Counsel | 06.05.2012 |
| GSK PLC | Corporate Officer/Principal | 01.01.2005 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01.08.1999 |
Ausbildung von Douglas Snyder
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Columbus School of Law
 Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
